Glucagon-like peptide 1 and type 1 diabetes: NOD ready for prime time?

被引：5

作者：

Hadjiyanni, Irene ^{[1
]}

Drucker, Daniel J. ^{[1
]}

机构：

[1] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada

来源：

ENDOCRINOLOGY | 2007年 / 148卷 / 11期

关键词：

D O I：

10.1210/en.2007-1112

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5133 / 5135

页数：3

共 23 条

[1] Effect of exenatide on β cell function after islet transplantation in type 1 diabetes [J].

Al Ghofaili, Khalid ;

Fung, Michelle ;

Ao, Ziliang ;

Meloche, Mark ;

Shapiro, R. Jean ;

Warnock, Garth L. ;

Elahi, Darlush ;

Meneilly, Graydon S. ;

Thompson, David M. .

TRANSPLANTATION, 2007, 83 (01) :24-28

[2] Glucagon-like peptide I improved glycemic control in type I diabetes [J].

Margaret T Behme ;

John Dupré ;

Thomas J McDonald .

BMC Endocrine Disorders, 3 (1)

[3] TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes [J].

Belghith, M ;

Bluestone, JA ;

Barriot, S ;

Mégret, J ;

Bach, JF ;

Chatenoud, L .

NATURE MEDICINE, 2003, 9 (09) :1202-1208

[4] TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs [J].

Bisikirska, B ;

Colgan, J ;

Luban, J ;

Bluestone, JA ;

Herold, KC .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2904-2913

[5] Moving towards efficient therapies in type 1 diabetes: To combine or not to combine? [J].

Bresson, D. ;

von Herrath, M. .

AUTOIMMUNITY REVIEWS, 2007, 6 (05) :315-322

[6] ANTI-CD3 ANTIBODY INDUCES LONG-TERM REMISSION OF OVERT AUTOIMMUNITY IN NONOBESE DIABETIC MICE [J].

CHATENOUD, L ;

THERVET, E ;

PRIMO, J ;

BACH, JF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :123-127

[7] The biology of incretin hormones [J].

Drucker, DJ .

CELL METABOLISM, 2006, 3 (03) :153-165

[8] Glucagon-like peptides: Regulators of cell proliferation, differentiation, and apoptosis [J].

Drucker, DJ .

MOLECULAR ENDOCRINOLOGY, 2003, 17 (02) :161-171

[9] Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes [J].

Dupré, J ;

Behme, MT ;

McDonald, TJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3469-3473

[10] A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes [J].

Herold, KC ;

Gitelman, SE ;

Masharani, U ;

Hagopian, W ;

Bisikirska, B ;

Donaldson, D ;

Rother, K ;

Diamond, B ;

Harlan, DM ;

Bluestone, JA .

DIABETES, 2005, 54 (06) :1763-1769

← 1 2 3 →